Search results
Is Moderna Inc (NASDAQ: MRNA) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 1 day agoDuring the last session, Moderna Inc (NASDAQ:MRNA)’s traded shares were 4.04 million, with the beta value of the company hitting 1.70. At the end of the trading day, the & ...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 4 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 7 days agoModerna confirmed it's in discussions with the U.S. government to move forward with its bird flu...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 4 days agoCan Moderna bounce back for investors who buy the dip? To find out, let's look at some reasons the ...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 21 hours agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
Moderna CFO sells $97,237 in stock amid performance unit vesting By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) reported a recent transaction by Chief Financial Officer James M. Mock,...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map -Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 17 hours agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
Moderna director Noubar Afeyan sells shares worth over $2.9 million By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a total of $2,901,584 worth of company...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 4 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...